- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Pediatrix Medical Group Reports Q4 Earnings
Physician group's results fall short of Wall Street expectations
Published on Feb. 24, 2026
Got story updates? Submit your updates here. ›
Pediatrix Medical Group, Inc. (MD) reported fourth-quarter earnings of $33.7 million, or 40 cents per share. Adjusted earnings came to 50 cents per share, falling short of the average analyst estimate of 53 cents per share. The company posted revenue of $493.8 million in the period, beating Street forecasts.
Why it matters
Pediatrix Medical Group is a major provider of physician services, particularly in the pediatric space. Its quarterly earnings and revenue performance are closely watched by investors as indicators of the company's financial health and growth trajectory.
The details
Pediatrix Medical Group, based in Sunrise, Florida, reported fourth-quarter earnings that missed analyst expectations despite posting higher revenue. The company's adjusted earnings of 50 cents per share fell short of the average analyst estimate of 53 cents per share compiled by Zacks Investment Research. However, Pediatrix's revenue of $493.8 million in the quarter beat the $491.5 million that analysts had forecast.
- Pediatrix reported its fourth-quarter earnings on Thursday, February 19, 2026.
The players
Pediatrix Medical Group, Inc.
A physician group that provides a range of pediatric and obstetric services across the United States.
The takeaway
Pediatrix's mixed quarterly results highlight the ongoing challenges and competitive pressures facing healthcare providers, even as the company continues to generate substantial revenue. Investors will be closely watching the company's ability to improve profitability and meet analyst expectations in the quarters ahead.



